ApprovalTrail

Approval · Notice of Compliance 8399 · 2006

MATULANE: Notice of Compliance 8399

Issued November 8, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
8399
Date
November 8, 2006
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Revised indication for use in combination with other anticancer agents for the treatment of stage iii and iv hodgkin's disease
Therapeutic class
Antineoplastic

Products in this notice

BrandDINStatus today
MATULANENot yet assigned—

Medicinal ingredients